Haemonetics CEO Chris Simon to Speak at Raymond James Fireside Chat

Haemonetics Schedules CEO Fireside Chat at Raymond James Conference

Haemonetics Corporation says President and Chief Executive Chris Simon will take part in a fireside chat at the Raymond James 47th Annual Institutional Investors Conference on Monday, March 2, 2026. The session begins at 10:25 a.m. ET and is open to the public via a live webcast on the company’s Investor Relations site. A replay becomes available 12 hours after the event and remains on the site for 90 days.

Leadership Message Focuses on Plasma Collection, Hospital Technologies

In the fireside chat, Haemonetics is expected to outline operational priorities tied to its portfolio of hospital technologies and plasma-collection solutions that support blood centers and plasma centers. The company frames its offerings as an integrated suite designed to improve clinical workflows, increase efficiency in plasma operations and enable collection of in-demand blood components. Executives use these investor-facing forums to explain how product development and service models aim to advance standards of care and patient outcomes across hospital and transfusion settings.

Management also plans to highlight how end-to-end plasma collection technologies fit within broader industry trends, such as rising demand for plasma-derived therapies and the need for optimized center operations. Haemonetics situates its technology road map against pressures on blood and plasma supply chains, regulatory scrutiny and the push for automation and data-driven management in clinical environments. The discussion gives the company a public platform to describe concrete steps it is taking to support customers — from device deployment and training to remote monitoring and throughput enhancements.

Webcast Access and Replay Details

The live webcast is accessible via Haemonetics’ Investor Relations website or directly at the provided Summitcast link. The company notes the replay is posted 12 hours after the live event and remains available for 90 days for those unable to join in real time.

Contacts and Corporate Profile

Haemonetics lists investor relations contacts Olga Guyette and David Trenk, and media contact Josh Gitelson, for follow-up. The company describes itself as a global medical-technology provider focused on hospital technologies, plasma collection systems and products for blood centers; further information is available at www.haemonetics.com.